SOURCE: BBK Worldwide

BBK Worldwide

June 27, 2016 09:00 ET

BBK Worldwide Unveils Scalable Mobile App Platform for Optimized Study Community Engagement

Flexible, Cloud-Based Platform Designed to Help Clinical Teams Utilize Patient- and Site-Facing Apps in Near Real-Time, at a Fraction of the Cost of Custom Development

BOSTON, MA--(Marketwired - June 27, 2016) - BBK Worldwide, an industry leader in patient recruitment and engagement technologies and services, today unveiled major updates to its award-winning mobile app platform. Powered by TrialCentralNet®, the only Patient Recruitment Management System (PRMS) of its kind, the comprehensive mobile app platform allows any clinical research or healthcare organization, including sponsors, CROs, and advocacy groups, to develop and utilize custom mobile apps in weeks instead of months, and at a small fraction of the cost of in-house development.

BBK developed the mobile app platform from the ground up expressly for clinical teams interested in leveraging the power of mobile apps to deliver a customized user experience and according to the needs of a specific study and patient community. Highly scalable, the BBK platform can be leveraged for six sites or 60, in dozens of languages and countries, and offer a variety of feature options for prescreening, study guidelines and study visit schedules. What's more, by utilizing BBK's comprehensive configuration model, sponsors and CROs can support sites and study teams confidently knowing that they're delivering all study materials and communications via the industry's most reliable, scalable cloud-based recruitment system.

"Clinical teams are very interested in utilizing mobile apps within their studies -- yet they also understand that it's resource intensive and cost prohibitive to develop custom patient- and site-facing apps in-house," said Erica Mercado, BBK's VP of Market Innovation and Product Expansion. "We developed a highly scalable platform that allows clinical teams to blend custom user experiences with study management efficiency -- making it possible for studies of all sizes to leverage the power of mobile. It's a win-win."

BBK is participating in DIA 2016 this week in Philadelphia at booth #1610, where executives are available to discuss the new platform and demo its suite of mHealth and patient recruitment and engagement solutions. Members of the media and analyst communities interested in meeting with BBK at the show can contact Juli Greenwood at 617-515-8412 or jgreenwood@bbkworldwide.com.

Follow @BBKWorldwide on Twitter and join the conversation with #DIA2016 and #BBKatDIA. For more information and to learn more please visit www.bbkworldwide.com/trialcentralnet/index.html.

Follow BBK

About BBK Worldwide

BBK Worldwide is the foremost patient recruitment and engagement technology firm, providing a range of award-winning creative services and technology solutions to the world's most innovative pharmaceutical and biopharmaceutical companies and their outsourced suppliers, such as CROs and eClinical providers. Committed to providing the support and solutions needed to improve patient engagement, enroll clinical studies on time, and expedite time-to-market, BBK delivers the industry's only suite of products built from the ground up to address the patient and site engagement challenges inherent in running large, multinational studies. Headquartered near Boston, Massachusetts, BBK has partners and offices across Europe and the Asia Pacific region. For more information, visit www.bbkworldwide.com.

Contact Information